BioSpace News Archive

Sensor based, real-time urine output monitoring system by RenalSense provides new value among patients in isolation

Ocean Bio-Chem, Inc. (NASDAQ: OBCI), has announced that its subsidiary manufacturing plant, Kinpak Inc. in Montgomery, Alabama has increased its number of shifts and is actively hiring additional personnel to try and meet overwhelming demand for its disinfectant product Performacide ® . In addition, they have taken steps t

Receptor Life Sciences (“RLS”), a leading biopharmaceutical company developing FDA regulated oral and inhaled cannabinoid medicines, today announced that the United States Patent and Trademark Office has issued the Company a Patent for compositions comprising cannabinoids and the company’s oral absorption enhancing excipients: U.S. Patent No. 10,588,974.

Immersion Neuroscience, the world’s most advanced predictive software company unlocking neuroscience to measure what people love, announced today a new Immersion Index revealing people’s reaction to celebrities’ vs. elected officials’ communications about the current COVID-19 pandemic.

Nordic Nanovector ASA (OSE: NANO) announces that its Nomination Committee has nominated Dr Karin Meyer, PhD for election as a Non-executive Director at the Company’s Annual General Meeting.

Blue Cross and Blue Shield of Illinois is responding to the coronavirus pandemic by offering additional options for telehealth services to give members improved access to care while reducing their risk of exposure.

Recently, scientists at Shanghai Institute of Materia Medica (SIMM) of Chinese Academy of Sciences, together with scientists at Institute of Biophysics (IBP) of Chinese Academy of Sciences and Monash University, determined two cryo-electron microscopy (cryo-EM) structures of the human glucagon receptor (GCGR) in complex with glucagon and distinct classes of G proteins, Gs or Gi.

The U.S. Food and Drug Administration today approved a supplemental application for Epclusa (sofosbuvir and velpatasvir) to treat hepatitis C virus (HCV) in children ages 6 years and older or weighing at least 37 pounds (17 kilograms) with any of the six HCV genotypes—or strains—without cirrhosis (liver disease) or with mild cir

-Caliwel™ BNA Coating has been proven effective against more than 20 life-threatening bacteria, viruses, and fungi; self-sanitizing protocol prevents new growth for up to 6 years. -Caliwel BNA treatment is authoritatively recognized and endorsed by the scientific community and general consumers as the most effective antimicrobial architectural solution in the market.

To facilitate rapid identification of COVID-19 cases, AACC has launched a directory of U.S. clinical laboratories that are, or will be, performing testing for SARS-CoV-2, the virus that causes COVID-19. This directory is designed to help healthcare providers quickly find laboratories that can diagnose patients suspected to have COVID-